PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

View/Open

Published version (2.345Mb)

Volume

19

DOI

10.1186/s13058-016-0789-y

Journal

BREAST CANCER RESEARCH

ISSN

1465-542X

Metadata

Show full item record

Authors

Shah, V; Nowinski, S; Levi, D; Shinomiya, I; Chaabouni, NKE; Gillett, C; Grigoriadis, A; Graham, TA; Roylance, R; Simpson, MA

URI

http://qmro.qmul.ac.uk/xmlui/handle/123456789/18926

Collections

Centre for Tumour Biology [348]

Licence information

Creative Commons Attribution 4.0

Copyright statements

© The Author(s). 2017